CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Prince Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Prince Pharmaceutical Co Ltd
No. 168, Keyun South Road, Kendi Village
Phone: +886 56326910p:+886 56326910 HUWEI, 632  Taiwan Ticker: 69356935

Business Summary
Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.
(Source: N-30D)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Corporate Governance Officer YingruJin 4/15/2023 4/15/2023
Independent Director Chin-HuaCheng
Independent Director YunyaoCheng
Independent Director DebinTao

General Information
Outstanding Shares: 36,605,000 (As of 6/30/2024)
Stock Exchange: TPO
Fax Number: +886 56320568


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024